The clock is ticking, and cytokinetics is running out of December
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: Business
STAT+: AAFP’s CEO on how to keep primary care doctors in the field
In ten years, the United States could be short as many as 48,000 primary care…
Morning Rounds: Why health care costs are nearly a fifth of the GDP
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
BioMarin appeases an activist
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
STAT+: Medical marijuana companies are using pharma’s sales tactics with little of the same scrutiny
WASHINGTON — Medical marijuana companies sell medicine, just like pharmaceutical companies. But they’re not playing…
STAT+: SEC charges former CEO of pain relief device company with $41 million fraud
The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company…
Morning Rounds: Have regulations on digital trackers in health care gone too far?
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
The biotech updates you need to read today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: The biggest health care deals of 2023
Every year, the health care industry behaves more and more like a balloon: Squeeze one…
FDA chastens pet companies over antibiotics
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Is it time to worry about Moderna?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
A plot to solve the ‘whack-a-mole’ of drug discovery
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Humana used algorithm in ‘fraudulent scheme’ to deny care to Medicare Advantage patients, lawsuit alleges
Medicare Advantage beneficiaries on Tuesday filed a class-action lawsuit alleging that the health insurance giant…
Morning Rounds: Can you take GLP-1 drugs during pregnancy?
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Tome Biosciences goes public today in another biotech megaround
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: STAT+: Dana-Farber CEO Laurie Glimcher has always been a trailblazer and a risk taker
Dr. Laurie Glimcher learned early on from her father, a prominent physician-researcher, that success in…
Morning Rounds: Preterm birth rates vary across the U.S., with the highest in the Southeast
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
The biotech news you missed from the weekend
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Tough road ahead for Bluebird Bio despite FDA approval for sickle cell therapy
The Food and Drug Administration’s approval on Friday of two gene therapies for sickle cell…
STAT+: Medicare’s advisory committee isn’t sold on big pay raises for doctors
On Thursday, the Medicare Payment Advisory Commission reviewed Medicare performance data and concluded that despite…
CRISPR is about to make history. Here’s the 5-minute rundown of what to expect
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT Health News: Abortion ‘companion networks,’ NEJM’s racist past, and other stories you need to read
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Eli Lilly’s latest $1.4 billion deal might come unglued
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Morning Rounds: Couples share high blood pressure, and other health stories you should read today
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Why Cerevel Therapeutics has risen 50% in three days without changing anything
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT Morning Rounds: The health news you need to read today
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Carmot’s chance of beating the odds in the biotech market just ended
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Novartis is building a new radioligand plant in China
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Johnson & Johnson bets heavy on AI-driven drug discovery
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Do GLP-1s have a future treating alcoholism?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: UnitedHealth Group now employs or is affiliated with 10% of all physicians in the U.S.
UnitedHealth Group has about 90,000 employed or affiliated doctors, approximately 10% of all physicians in…
Flagship Pioneering crosses the pond, opens a European front
Want to stay on top of the science and politics driving biotech today? Sign up to get…
A new algorithm unveils CRISPR ‘treasure trove’
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: U.S. Anesthesia Partners, Welsh Carson face class action over monopoly allegations
Union health plans that represent electricians and plumbers in Texas have filed a class action…
Medtronic isn’t afraid of Wegovy’s potential to disrupt
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Bayer’s new CEO was dealt a duo of ‘clearing events.’ Tough choices lie ahead
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Merck cough drug doesn’t pass panel scrutiny
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The return of biotech’s “bump factor” amid an economic downturn
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Doctors divide over reforming a secretive panel that determines their Medicare pay
WASHINGTON — Doctors are splitting, specialty by specialty, over whether and how to overhaul a…
How do we know Alzheimer’s drugs ‘work’?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The apparently strong correlation between biotech stocks and the price of eggs, explained
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: UnitedHealth faces class-action lawsuit over algorithmic care denials in Medicare Advantage plans
A class-action lawsuit was filed Tuesday against UnitedHealth Group and a subsidiary alleging that they…
Opinion: Patent buyouts could spur vital innovation in antibiotics, vaccines, and other medical fields
The announcement by the Center for Medicare and Medicaid Services that ten drugs will be…
Novo Nordisk has its sights on becoming a major player in heart disease
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: What Amazon Prime’s new One Medical offering reveals about the future of health care
Amazon Prime members have a new offer in addition to the usual delivery and streaming…
The first vaccine for the increasingly prevalent chikungunya virus is here
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Digital health startups need more doctor CEOs
In my decade living in Silicon Valley as a digital health journalist and now an…
Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis
Want to stay on top of the science and politics driving biotech today? Sign up to get…